Use of IL-2 gene transfer in local immunotherapy of cancer
- 1 March 1992
- journal article
- Published by Elsevier in Cancer Letters
- Vol. 62 (3) , 257-262
- https://doi.org/10.1016/0304-3835(92)90104-4
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Immunotheraphy of cancer using local administration of lymphoid cells transformed by IL-2 cDNA and constitutively producing IL-2Immunology Letters, 1990
- Local immunotherapy of cancer with interleukin 2Immunology Letters, 1989
- Treatment of recurrent squamous cell carcinoma of the head and neck with low doses of lnterleukin-2 injected periiymphaticallyCancer, 1988
- Local administration of cells containing an inserted IL-2 gene and producing IL-2 inhibits growth of human tumours in nu/nu miceImmunology Letters, 1988
- Establishment of mouse cell lines which constitutively secrete large quantities of interleukin 2, 3, 4 or 5, using modified cDNA expression vectorsEuropean Journal of Immunology, 1988
- Constant-Infusion Recombinant Interleukin-2 in Adoptive Immunotherapy of Advanced CancerNew England Journal of Medicine, 1987
- Tumour inhibitory effects of TCGF/IL-2/-containing preparationsCancer Immunology, Immunotherapy, 1985
- Tumour regression after intralesional injection of interleukin 2 (IL-2) in bladder cancer. Preliminary reportInternational Journal of Cancer, 1984
- Growth inhibition of a MC-induced mouse sarcoma by TCGF (IL 2)-containing preparationsCancer Immunology, Immunotherapy, 1983
- Rous sarcomas induced by heterotransplantation of virogenic rat tumour cells in miceInternational Journal of Cancer, 1972